The Role of HMGB-1 in Chronic Stroke

NCT01705353 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 39

Last updated 2018-03-12

No results posted yet for this study

Summary

The purpose of this study is to measure the presence of HMGB-1 and other proteins in the blood across five time points after stroke, and to determine if their presence correlates with rate of stroke recovery.

Conditions

  • Cerebrovascular Accident
  • Cerebral Stroke
  • Stroke, Acute

Sponsors & Collaborators

  • Northwell Health

    lead OTHER

Principal Investigators

  • Bruce T Volpe, MD · Feinstein Institute for Medical Research

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2017-12-31
Completion
2018-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01705353 on ClinicalTrials.gov